Scientists at the Baylor College of Medicine and the University of Michigan Medical School reported that a subset of immune B cells, known as CD19+IgM+ B cells, can delay the onset of type 1 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback